Senator Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Senator Investment Group's BMY Position: Q1 2021 in Review
Senator Investment Group sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 900,000 shares — an estimated $55.8M sold.
Senator Investment Group first reported a position in BMY in Q4 2019 and held it in 4 quarters. The position peaked at $55.8M in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- Senator Investment Group reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
- Senator Investment Group sold 900,000 Bristol-Myers Squibb shares in Q1 2021, an estimated $55.8M.
- Senator Investment Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 4 quarters.
- Senator Investment Group's Bristol-Myers Squibb position peaked at $55.8M in Q4 2020.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on Senator Investment Group's 13F filing for Q1 2021, filed 17 May 2021.